# Caris Life Sciences, Inc.: filings

CAI · Nasdaq · CIK 2019410 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cai.md) · [Financials](/companies/cai/financials.md) · [Filings](/companies/cai/filings.md) · [Insiders](/companies/cai/insiders.md)

## Reports and events: 20 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 50, 3 17, 8-K 11, 144 8, SCHEDULE 13G/A 6, DRS/A 5, SCHEDULE 13G 5, 10-Q 4, DRSLTR 4, UPLOAD 4, 8-A12B 2, CERT 2, CORRESP 2, S-1/A 2, 10-K 1, 424B4 1, ARS 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, S-1 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 16:38 ET | [8-K](/filings/0002019410-26-000061.md) | 7.01 Regulation FD disclosure | 0002019410-26-000061 |
| 2026-08-05 | 17:00 ET | [10-Q](/filings/0002019410-26-000055.md) | Quarterly report, period 2026-06-30 | 0002019410-26-000055 |
| 2026-08-05 | 16:12 ET | [8-K](/filings/0002019410-26-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-26-000053 |
| 2026-06-05 | 17:03 ET | [8-K](/filings/0002019410-26-000046.md) | 5.07 Shareholder vote results | 0002019410-26-000046 |
| 2026-05-08 | 16:13 ET | [10-Q](/filings/0002019410-26-000044.md) | Quarterly report, period 2026-03-31 | 0002019410-26-000044 |
| 2026-05-07 | 16:14 ET | [8-K](/filings/0002019410-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-26-000040 |
| 2026-04-23 | 06:23 ET | [DEF 14A](/filings/0002019410-26-000032.md) | Proxy statement, period 2026-06-04 | 0002019410-26-000032 |
| 2026-04-02 | 16:28 ET | [8-K](/filings/0002019410-26-000019.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0002019410-26-000019 |
| 2026-03-03 | 16:09 ET | [10-K](/filings/0002019410-26-000016.md) | Annual report, period 2025-12-31 | 0002019410-26-000016 |
| 2026-02-26 | 16:11 ET | [8-K](/filings/0002019410-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002019410-26-000011 |
| 2026-01-12 | 09:00 ET | [8-K](/filings/0002019410-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002019410-26-000005 |
| 2025-11-05 | 17:01 ET | [10-Q](/filings/0002019410-25-000028.md) | Quarterly report, period 2025-09-30 | 0002019410-25-000028 |
| 2025-11-05 | 16:17 ET | [8-K](/filings/0002019410-25-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-25-000026 |
| 2025-10-30 | 16:20 ET | [8-K](/filings/0002019410-25-000020.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0002019410-25-000020 |
| 2025-08-12 | 16:59 ET | [10-Q](/filings/0002019410-25-000012.md) | Quarterly report, period 2025-06-30 | 0002019410-25-000012 |
| 2025-08-12 | 16:10 ET | [8-K](/filings/0002019410-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-25-000011 |
| 2025-06-20 | 16:05 ET | [8-K](/filings/0001104659-25-061148.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061148 |
| 2025-06-16 | 07:01 ET | [S-1/A](/filings/0001104659-25-059635.md) | Registration statement, amended | 0001104659-25-059635 |
| 2025-06-09 | 07:05 ET | [S-1/A](/filings/0001104659-25-057593.md) | Registration statement, amended | 0001104659-25-057593 |
| 2025-05-23 | 15:27 ET | [S-1](/filings/0001104659-25-052381.md) | Registration statement | 0001104659-25-052381 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.